Thailand Could Seek WTO Solution On Compulsory Licensing, Generic Drugs
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Multinational drug companies and authorities across developed countries have censured Thailand for using compulsory licensing - a method of forcing pharmaceutical outfits holding patents on innovative medicines to allow other companies to turn out the product
You may also be interested in...
After Ending Protests, Thai Leadership Aims To Reassure Foreign Firms, Investors
SHANGHAI - After using the military to clear Bangkok of protesters, the Thai government is mounting a peaceful offensive, armed with an arsenal of favorable tax and investment policies, to encourage international businesses to stay put or set up shop in Thailand
After Ending Protests, Thai Leadership Aims To Reassure Foreign Firms, Investors
SHANGHAI - After using the military to clear Bangkok of protesters, the Thai government is mounting a peaceful offensive, armed with an arsenal of favorable tax and investment policies, to encourage international businesses to stay put or set up shop in Thailand
China’s 2009 Regulatory Changes Will Affect Makers of Drugs, APIs and Devices
BEIJING - An array of regulatory and legal changes covering pharmaceuticals and medical devices in China is likely to be launched or broadened this year, including new GMP guidelines, as the country aims to upgrade supervision of the entire health care sector, according to a leading Chinese lawyer in the area of life sciences-related issues and legislation